Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Kate Falberg, John Thompson, Charles Wagner

Premium

Ariosa Diagnostics has elected Kate Falberg to its board of directors and to chair of the audit committee. Falberg most recently served as executive vice president and CFO of Jazz Pharmaceuticals. She also held various roles at Amgen, including as senior vice president of finance and strategy and CFO. Currently, she serves on the board of directors and is chair of the audit committee of Halozyme Therapeutics and Medivation.


John Thompson is now senior director of research and development at Claritas Genomics. Previously, he was senior director of applications and external collaboration at next-generation sequencing firm Nabsys and before that was senior director of genomic research at Helicos BioSciences. He holds a PhD in biophysical chemistry from the University of California, Berkeley and a BS in chemistry from Yale University.


Good Start Genetics has appointed Charles Wagner to its board of directors. Wagner is currently CFO and executive vice president of finance and administration of Bruker Corporation. He has also served as CFO and executive vice president of finance and administration at Progress Software Corporation and CFO and vice president of Millipore Corporation. He holds an MBA from Harvard University and a BS from Boston College.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.